Bicycle Therapeutics shares fall 23% after the company shares interim Phase 1 data

cafead

Administrator
Staff member
  • cafead   Apr 11, 2022 at 10:52: AM
via Shares of Bicycle Therapeutics Inc. BCYC, -30.10% tumbled 23.4% in premarket trading on Monday after the company shared interim data from a Phase 1 clinical trial for its urothelial-cancer treatment.

article source